Management of prostate cancer. Part 3: metastatic disease.

Journal article

Despite the increased detection of prostate cancer at an early stage, men are still dying of this disease. Management of advanced disease focuses on controlling the disease process, palliation of symptoms and improving quality of life. In this review, the basis for androgen deprivation in hormone-dependent disease is discussed and the role of maximum and intermittent androgen deprivation, as well as management options for hormone-refractory disease is addressed. Local radiotherapy continues t...

Expand abstract

Authors: Shah, J; Khaksar, S; Sooriakumaran, P

• Journal: Expert review of anticancer therapy
• Volume: 6
• Issue: 5
• Pages: 813-821
• Publication date: 2006-05-01
• DOI: 10.1586/14737140.6.5.813
• EISSN: 1744-8328
• ISSN: 1473-7140
• Language: English
• Keywords: Prostatic Neoplasms; Male; Diphosphonates; Immunotherapy; Humans; Drug Resistance, Neoplasm; Angiogenesis Inhibitors; Neoplasm Metastasis; Radiopharmaceuticals; Survival Analysis; Androgen Antagonists; Androgens